INDUSTRY × Pancreatic Neoplasms × Classical hematology × Clear all CATIQ P3
Phase 3 Recruiting
480 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Phase 1 Completed
113 enrolled 39 charts
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Completed
1,262 enrolled 14 charts
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
30 enrolled
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Phase 2 Completed
73 enrolled